American Academy of FertilityCare Professionals CONFERENCE, Albuquerque, USA July 2006

The Annual conference for FertilityCare Professionals was held in Albuquerque, New Mexico this July 2006. This year we gained important new insights regarding the causes of unusual menstrual bleeding as presented by Dr. Thomas Hilgers. The International Institute of Restorative Reproductive Medicine (www.iirrm.org) updated us on most recent developments regarding research efforts into NaProTECHNOLOGY and Professor Joseph Stanford gave an excellent presentation on the Medical, Ethical and Social dimensions of Emergency Contraception.

Dr. Phil Boyle gave a powerpoint presentation on new uses of Low Dose Naltrexone for treating infertility, available HERE.

The powerpoint slides used in the presentation are also available to download HERE (note...this can take a while to download as it is a large file!)

Chuck Weber updated us on the media treatment of fertility issues and gave insights into how we can get the word out about what FertilityCare has to offer instead of the contemporary approach.

American Academy of FertilityCare Professionals CONFERENCE, Florida, USA July 2005

The Annual conference for FertilityCare Professionals was held in St. Petersburg, Florida this July 2005.

The conference was well attended by Doctors and Practitioners from all over the USA, Australia, Canada, UK and Ireland. We were treated to excellent presentations from Dr. Hilgers and Prof. Janet Smith. Tape recordings and a list of all topics covered from the conference are available until 26th August from www.aafcp.org.

NaProTECHNOLOGY CONFERENCE July 2004

A major international conference entitled “Introducing NaProTechnology to the world: Medical Science at the Service of the Human Person” was held in Omaha, Nebraska USA last July (2004). It  was a tremendous success.  The conference was attended by nearly 400 people, including medical professionals and allied healthcare providers representing 15 different countries. Several couples who have benefited personally from NaProTECHNOLOGY spoke of their experience. One couple were interviewed by reporters and their story was broadcast to over 2 million homes in the USA.

Their interview can be seen at www.saintmaxworldwide.org

First Paper published on LDN Jan 07

LDN (Low Dose Naltrexone) is an immune modifying treatment that has been used as part of NaProTechnology fertility treatment since 2004. Clinical experience in the use of this medication is very positive but until now there were no published scientific papers to demonstrate the immune modifying properties of LDN. At last Professor Jill Smith et al have published a pilot study demonstrating the effectiveness of LDN in Crohn's disease...a condition caused by the immune system attacking the digestive tract. Click HERE for an abstract of the study from the American Journal of Gastroenterology 2007.

Recent Study Links Hormonal contraceptive use with Breast Cancer

The journal of the Mayo Clinic (Mayo Clinic Proceedings) has published a key article in it’s October 2006 issue entitled “Oral Contraceptive Use as a Risk Factor for Pre-menopausal Breast Cancer: A Meta-analysis”, authored by Chris Kahlenborn, M.D., (Internal Medicine, Altoona Hospital, PA), Francesmary
Modugno, Ph.D., (Epidemiology), Douglas M. Potter, Ph.D. (Biostatistics) both from the University of Pittsburgh, and Walter B. Severs, Ph.D., Professor Emeritus of Pharmacology at the Penn State College of Medicine. The major findings from this careful analysis of the world literature were that oral ontraceptives (OCs) were linked with a measurable and statistically significant association with pre-menopausal breast cancer. The risk association was 44% over baseline in parous women (having been pregnant) who took OCs prior to their first pregnancy. For article and graph click here.  Full article HERE.